Melanoma vs. Normal Mole: How to Tell the Difference

Why the Distinction Matters

Melanoma is the deadliest form of skin cancer, responsible for the great majority of skin cancer deaths despite representing only about 1% of skin cancer cases by volume. Early-stage melanoma confined to the skin is highly curable — five-year survival rates for localized melanoma exceed 98%. Metastatic melanoma — spread to lymph nodes or distant organs — carries a dramatically worse prognosis.

The difference between an early diagnosis and a late one often comes down to a patient recognizing a warning sign early and seeking evaluation. This guide provides the clinical framework dermatologists use to distinguish melanoma from a benign melanocytic naevus (mole), translated into language that supports confident self-screening — while being clear about the limits of self-assessment.

Normal Moles: What They Look Like

A benign melanocytic naevus forms from clusters of melanocytes — the pigment-producing cells of the skin — that group together instead of spreading evenly. Virtually everyone has moles; most adults have between 10 and 40. Moles are not dangerous in themselves, though they are the tissue from which some melanomas arise.

Characteristics of a normal, benign mole:

Normal moles may be flat or raised, light or dark — variation in these features is normal. What matters is internal consistency and stability over time.

Melanoma: What It Looks Like

Melanoma arises when melanocytes undergo malignant transformation, acquiring DNA mutations — most commonly triggered by UV radiation — that cause uncontrolled, disorganized growth. Because this growth is disorganized, the visual hallmarks of melanoma reflect that chaos: irregular shapes, variable pigmentation, and an inability to maintain stable boundaries.

The ABCDE rule was developed to capture these features in a memorable, teachable framework.

The ABCDE Rule: A Side-by-Side Comparison

A — Asymmetry

Asymmetry is the most visually obvious discriminating feature in established melanomas. Even in early lesions, asymmetric growth is one of the first manifestations of the disorganized cell division characteristic of malignancy.

B — Border

A melanoma's border may look as if it has been smudged outward, or it may have serrated, scalloped, or jagged projections. The border may appear to fade into the surrounding skin rather than end clearly. Pigment spreading beyond the visible edge of the lesion — into the surrounding normal skin — is a particularly concerning sign.

C — Color

Color variation within a single lesion is one of the most reliable discriminators. The American Cancer Society notes that concerning lesions may contain "different shades of brown or black, or sometimes with patches of pink, red, white, or blue." DermNet NZ's clinical documentation indicates melanomas may contain up to five or six distinct colors distributed unevenly.

Areas of white or lighter color within a dark lesion may represent regression — areas where the immune system is partially destroying tumor tissue. Pale, white areas within a pigmented lesion are therefore not reassuring; they can indicate an active malignant process.

Areas of red reflect inflammation; blue reflects deeply distributed pigment that scatters light before reaching the surface.

D — Diameter

The 6mm threshold exists because most melanomas have grown larger than this by the time they present to a dermatologist. However, it is important to understand that diameter alone is neither sensitive nor specific:

• Not all melanomas are large — thin, early melanomas may be well under 6mm. Applying the 6mm rule rigidly can produce false reassurance about small lesions that are nevertheless changing or displaying other ABCDE features.
• Not all large moles are melanomas — some people naturally have benign moles larger than 6mm that have been stable for decades.

A useful clinical refinement: some dermatologists now interpret "D" as "Dark" — a lesion significantly darker than all of the patient's other moles warrants evaluation even if it is under 6mm.

E — Evolving

This is arguably the most actionable criterion. A mole that has been stable for 20 years and suddenly begins to change — even subtly — has lost its reassuring quality. New bleeding, crusting, tenderness, or itching in a previously asymptomatic mole are warning signs that complement visible changes.

Monthly self-examination with a documented baseline (photographs) makes it far easier to detect evolving changes that might otherwise be dismissed as imperceptible.

The Ugly Duckling Sign: The Essential Complement to ABCDE

The ABCDE rule evaluates individual moles in isolation. The ugly duckling sign corrects for this limitation by comparing each mole to the gestalt of the patient's other moles.

Most people develop moles with a broadly consistent "theme" — similar size, color, and shape across most of their moles. A lesion that stands out as dramatically different from all the others — darker, larger, more irregular, lighter, or simply anomalous — is an ugly duckling and should be evaluated even if it does not clearly trigger specific ABCDE criteria.

A PMC-published review proposed formalizing this into the ABCDEF rule by adding "F for Funny looking" to capture the gestalt impression that something looks wrong, even when an explicit criterion cannot be named.

Critical Exception: Nodular Melanoma and the EFG Criteria

Nodular melanoma is one of the most dangerous melanoma subtypes — it accounts for up to 14% of melanomas but a disproportionate share of melanoma deaths. The reason is biological: nodular melanoma grows primarily vertically (into the dermis) rather than radially across the surface. This means it can reach a lethal depth while remaining visually unimpressive by ABCDE standards.

Nodular melanoma may present as:

• A small, symmetrical, dome-shaped nodule
• Uniform dark blue, black, or pink color
• Well-defined or even smooth borders
• Under 6mm — especially early on
• No evolving changes noticed (because it grows rapidly but was not being tracked)

Because ABCDE poorly identifies nodular melanoma, DermNet NZ and other clinical sources recommend the EFG criteria for this subtype:

A new, firm, raised, fast-growing lesion — regardless of ABCDE status — requires urgent clinical evaluation.

Side-by-Side Summary: Mole vs. Melanoma

What to Do If You Spot a Concerning Lesion

1. Do not wait. If a lesion concerns you, book a dermatologist appointment promptly. Melanoma is a time-sensitive diagnosis. "Watching it for a few more months" is not a safe strategy for a lesion displaying warning signs.

2. Do not attempt to diagnose it yourself. The ABCDE rule and ugly duckling sign are triage tools, not diagnostic tools. Dermoscopy — examination under polarized light with a dermatoscope — significantly improves clinical diagnostic accuracy over the naked eye, and biopsy with histopathological analysis is the only definitive method for excluding or confirming melanoma.

3. Photograph the lesion and document when you first noticed it and what prompted concern. This history helps the dermatologist contextualize the finding.

4. At the dermatologist's office: If the dermatologist is concerned after clinical and dermoscopic evaluation, a biopsy will be performed — usually an excisional biopsy (the entire lesion removed with a small margin) or a punch biopsy. Histopathological analysis by a dermatopathologist provides the definitive diagnosis.

When a Mole Becomes Higher Risk: Dysplastic Nevi

Some people have moles that are atypical or dysplastic — moles that display some but not all ABCDE features and are considered intermediate between a normal mole and melanoma. Dysplastic nevi are not cancer, but they are a risk marker:

• People with multiple dysplastic nevi have a higher lifetime risk of melanoma
• A single dysplastic nevus in isolation does not dramatically increase risk
• Dysplastic nevi should be monitored; those with features of high-grade atypia on biopsy are often excised with clear margins

The presence of dysplastic nevi warrants closer surveillance and professional monitoring — typically every 6–12 months with whole-body photography.

Common Look-Alikes: Not Every Dark Spot Is a Mole or Melanoma

The differential diagnosis for a pigmented lesion is broad. Conditions that can mimic moles or melanoma include:

• Seborrheic keratoses: Common, benign "stuck-on" growths that are dark, waxy, and warty-appearing; very commonly mistaken for melanoma by patients. They are especially common in people over 50.
• Dermatofibromas: Firm, slightly raised, brownish nodules that often have a subtle dimple when pinched; benign.
• Blue nevi: Benign moles with deep pigment that appears blue-gray on the surface; can be confused with nodular melanoma.
• Hemangiomas: Blood vessel growths that may appear dark red or dark purple; not cancerous.
• Pigmented basal cell carcinoma: In darker skin tones, BCC may appear brown or black and be mistaken for a mole; it requires different treatment.

This is another reason professional evaluation is essential — clinical and dermoscopic assessment by a trained dermatologist is far more accurate than naked-eye assessment of photographs or self-examination alone.